in what cryptocurrency to invest Top Top stories

Guoxuan Hi-Tech: China, the strategic shareholder, continued to give up voting rights. Guoxuan Hi-Tech announced that Guoxuan Holdings, Li Zhen and Jerry Lee (collectively referred to as the "founding shareholders") and China, the strategic shareholder of the company, signed a Supplementary Agreement on the Shareholders' Agreement of Guoxuan Hi-Tech Co., Ltd., and Volkswagen China agreed to extend the commitment period of giving up voting rights. That is to say, within 72 months after the relevant shares of the company involved in the non-public offering and share transfer are registered in the name of Volkswagen China or within a longer period determined by Volkswagen China, it will irrevocably give up the voting rights of some of its shares in the company, so that the voting rights of Volkswagen China will be at least 5% lower than that of the founding shareholder. Volkswagen China's extension of the period of giving up its voting rights commitment this time will not lead to the change of the company's control rights and will not affect the normal production and operation of the company. Mr. Li Zhen remains the actual controller of the company.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)European Central Bank: It is estimated that the GDP growth rate will be 0.7% in 2024, 1.1% in 2025, 1.4% in 2026 and 1.3% in 2027. (It is expected to be 0.8%, 1.3% and 1.5% respectively in September) It is estimated that the core inflation rate will be 2.9% in 2024, 2.3% in 2025 and 1.9% in 2026. (It is expected to be 2.8%, 2.3% and 2.0% respectively in September) It is estimated that the core inflation rate will be 1.9% in 2027.

The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.The Korea Composite Index closed up 1.60%.Trade union representative: STELLANTIS told us that the output of Italy in 2025 will be similar to this year, about 500,000 vehicles.

The main fuel contract rose by 6.00% in the day and is now reported at 3249.00 yuan/ton.European Central Bank: It plans to stop reinvesting in the Emergency Anti-epidemic Bond Purchase Program (PEPP) by the end of 2024. Continue to reduce the emergency anti-epidemic bond purchase program (PEPP) by 7.5 billion euros per month.ECB: The appropriate monetary policy stance will be determined by data dependence and successive meetings. Inflation prospect, core inflation and its transmission will determine the interest rate path.